Masaki Tsuji, Daisuke Nitta, Shun Minatsuki, Hisataka Maki, Yumiko Hosoya, Eisuke Amiya, Masaru Hatano, Eiki Takimoto, Osamu Kinoshita, Kan Nawata, Minoru Ono, Issei Komuro
Heart transplantation (HTx) is the gold standard therapy to improve quality and quantity of life in end-stage heart failure patients. However, recipients are at risk of experiencing allograft rejection and post-transplant complications, in the acute as well as chronic phase. A 43-year-old man with a history of left ventricular non-compaction underwent orthotopic HTx. On Day 7, transthoracic echocardiography showed a sudden decrease in cardiac function with hypokinesis in a left ventricular anterior wall distribution...
March 10, 2019: ESC Heart Failure